Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/02/2024 → 31/01/2027 |
Collaborative partners
- King's College London (lead)
- Queen's University Belfast
- University of York
- Ludger Ltd.
Funding
- Worldwide Cancer Research: £274,911.14
Glycoengineering of optimal IgE antibodies for cancer therapy
- Karagiannis, Sophia (Primary Investigator)
Project: Research